Regulation of serine protease inhibitor Kazal type-5 (SPINK5) gene expression in the keratinocytes

Environmental Health and Preventive Medicine

Volumn 19, Issue 4, 2014, Pages 307-313

  Le, Ngoc Anh ^a   Katsuyama, Midori ^a   Demura, Masashi ^a   Tanii, Hideji ^a   Katsuyama, Hironobu ^b   Saijoh, Kiyofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

GATA3; Human keratinocyte; Serine protease inhibitor Kazal type 5 (SPINK5); Transcription regulation

Indexed keywords

KALLIKREIN; SERINE PROTEASE INHIBITOR KAZAL TYPE 5; SERINE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG; GATA3 PROTEIN, HUMAN; LEUKOCYTE ELASTASE INHIBITOR; LUCIFERASE; SPINK5 PROTEIN, HUMAN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA FOOTPRINTING; ENZYME ACTIVITY; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; LUCIFERASE ASSAY; PROTEIN EXPRESSION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION;

BASE SEQUENCE; CELLS, CULTURED; DNA FOOTPRINTING; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; LUCIFERASES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE PROTEINASE INHIBITORS; TRANSFECTION;

EID: 84904130348     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1007/s12199-014-0393-7     Document Type: Article

References (26)

1. North AJ, Bardsley WG, Hyam J, Bornslaeger EA, Cordingley HC, Trinnaman B, et al. Molecular map of the desmosomal plaque. J Cell Sci. 1999;112:4325-36. (Pubitemid 30122024)
2. Angst BD, Marcozzi C, Magee AI. The cadherin superfamily: diversity in form and function. J Cell Sci. 2001;114:629-41. (Pubitemid 32237135)
3. Murphy G. Istology of the skin. In: Edler D, et al., editors. Lever's istopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven Publishers; 1997. p. 5-29.
4. Yousef GM, Diamandis EP. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr Rev. 2001;22:184-204. (Pubitemid 32458158)
5. Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, Takehara K, et al. Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J Invest Dermatol. 2003;121:542-9. (Pubitemid 37072266)
6. Komatsu N, Saijoh K, Sidiropoulos M, Tsai B, Levesque MA, Elliott MB, et al. Quantification of human tissue kallikreins in the stratum corneum: dependence on age and gender. J Invest Dermatol. 2005;125:1182-9.
7. Halprin KM. Epidermal "turnover time" a re-examination. Br J Dermatol. 1972;86:14-9.
8. Pierard GE, Goffin V, Hermanns-Le T, Pierard-Franchimont C. Corneocyte desquamation. Int J Mol Med. 2000;6:217-21.
9. Ya-Xian Z, Suetake T, Tagami H. Number of cell layers of the stratum corneum in 304 normal skin - relationship to the anatomical location on the body, age, sex and physical parameters. Arch Dermatol Res. 1999;291:555-9.
10. Harding K. Challenges for skin and wound care in the new century. Adv Skin Wound Care. 2000;13(212):215.
11. Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet. 2000;25:141-2. (Pubitemid 30394980)
12. Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K, et al. Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol. 2002;118:436-43. (Pubitemid 34227160)
13. Komatsu N, Saijoh K, Jayakumar A, Clayman GL, Tohyama M, Suga Y, et al. Correlation between SPINK5 gene mutations and clinical manifestations in Netherton syndrome patients. J Invest Dermatol. 2008;128:1148-59. (Pubitemid 351543199)
14. Komatsu N, Saijoh K, Toyama T, Ohka R, Otsuki N, Hussack G, et al. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases. Br J Dermatol. 2005;153:274-81. (Pubitemid 41228422)
15. Do NS, Li L, Katsuyama H, Komatsu N, Saito M, Tanii H, et al. Abundant expression of Kallikrein 1 gene in human keratinocytes was mediated by GATA3. Gene. 2009;436:121-7.
16. Matsui T, Hayashi-Kisumi F, Kinoshita Y, Katahira S, Morita K, Miyachi Y, et al. Identification of novel keratinocyte-secreted peptides dermokine-alpha/-beta and a new stratified epithelium-secreted protein gene complex on human chromosome 19q13.1. Genomics. 2004;84:384-97. (Pubitemid 38834175)
17. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics. 2002;18:333-4. (Pubitemid 34183117)
18. Farre D, Roset R, Huerta M, Adsuara JE, Rosello L, Alba MM, et al. Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucl Acids Res. 2003;31:3651-3. (Pubitemid 37442215)
19. Broos S, Soete A, Hooghe B, Moran R, van Roy F, De Bleser P. PhysBinder: improving the prediction of transcription factor binding sites by flexible inclusion of biophysical properties. Nucl Acids Res. 2013;41:W531-4.
20. Abmayr SM, Yao T, Parmely T, Workman JL. Preparation of nuclear and cytoplasmic extracts from mammalian cells. Curr Protoc Mol Biol. 2006. doi:10.1002/0471142727.mb1201s75.
21. Liu Q, Xia Y, Zhang W, Li J, Wang P, Li H, et al. A functional polymorphism in the SPINK5 gene is associated with asthma in a Chinese Han Population. BMC Med Genet. 2009;10:59.
22. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, et al. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol. 1990;144:326-32.
23. Poumay Y, Pittelkow MR. Cell density and culture factors regulate keratinocyte commitment to differentiation and expression of suprabasal K1/K10 keratins. J Invest Dermatol. 1995;104:271-6.
24. Assumpcao JG, Benedetti CE, Maciel-Guerra AT, Guerra G Jr, Baptista MT, Scolfaro MR, et al. Novel mutations affecting SRY DNA-binding activity: the HMG box N65H associated with 46, XY pure gonadal dysgenesis and the familial non-HMG box R30I associated with variable phenotypes. J Mol Med. 2002;80:782-90. (Pubitemid 35478126)
25. Sun J, He H, Pillai S, Xiong Y, Challa S, Xu L, et al. GATA3 transcription factor abrogates Smad4-mediated fascin overexpression, invadopodium formation and breast cancer cell invasion. J Biol Chem. 2013;288:36971-82.
26. Masse I, Barbollat-Boutrand L, Kharblili ME, Berthier-Vergnes O, Aubert D, Lamantine J. GATA3 inhibits proliferation and induces expression of both early and late differentiation markers in keratinocytes of the human epidermis. Arch Dermatol Res. 2014;306(2):201-8. doi:10.1007/s00403-013-1435-5.